Shoulder Innovations, Inc. (SI)
NYSEHealth CareMedical - SpecialtiesSnapshot 2026-09-04
$20.32-0.34%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - SpecialtiesSnapshot 2026-09-04
QuarterlyIQ Insights · SI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -6.2% |
| Our one-year growth estimate | diamond | 33.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 40.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 8 industry peers · Company calendar date is not available
SI — earnings in line
Dated 2026-08-06
Results of Operations and Financial Condition. On August 6, 2026, Shoulder Innovations, Inc. (the “Company”) issued a press release announcing financial results for the second quarter ended June 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Current Report on Form 8-K (including Exhibit 99.1 hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as am…
Why it matters: A big drop in cash might show liquidity problems. This can hurt operations and growth.
Worry ifCash and cash equivalents fall below $90 million by Q3 2026.
Less concerning ifCash and cash equivalents remain above $90 million by Q3 2026.
Why it matters: This would indicate that the company is struggling to meet its growth targets. It could signal issues with sales or market demand.
Worry ifQ3 2026 revenue growth reported below 42% compared to Q3 2025.
Less concerning ifQ3 2026 revenue growth meets or exceeds 42% compared to Q3 2025.
Why it matters: Good cash management is key for keeping operations running and funding growth.
Watch forCash flow gets better after new credit facilities. This shows good liquidity management.
Also watch forCash flow gets worse even with new credit facilities. This shows poor financial health.
Why it matters: Successful product launches show the company is innovative. This can help increase sales.
Supportive ifSurgeons gave positive feedback. Initial sales numbers for the N-22 glenosphere and TPS baseplate are good.
Worry ifNegative feedback or low sales numbers for these new products are concerning.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$238 on $10,000 · ±2.4% | How much price usually moves either way. |
| Bad day | $561 loss on $10,000 · 5.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,075 loss on $10,000 · 30.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Better cash flow means better money management. This shows a healthier operation.
Supportive ifCash from operations was less than negative $12.36 million in Q2 2026.
Worry ifCash from operations was more than negative $12.36 million in Q2 2026.
Why it matters: Better cash flow means more money available. This helps keep operations running and supports growth.
Supportive ifPositive cash flow is seen in Q3 2026 after new credit deals are closed.
Worry ifCash flow remains negative in Q3 2026 despite new credit facilities.
Why it matters: Using the new credit facilities well can help with cash flow and growth.
Supportive ifCompany uses the $30 million line of credit well for its needs.
Worry ifCompany does not use the new credit facilities or has cash flow problems.
Why it matters: A new building can support growth and operations. This is key for future expansion.
Supportive ifThe new commercial building is finished and open for business.
Worry ifConstruction delays push back the completion date.
Why it matters: Higher losses could show that spending on growth is not translating to revenue. This could impact investor confidence.
Worry ifOperating losses are over $10 million in Q3 2026.
Less concerning ifOperating losses remain at or below $10 million in Q3 2026.
Why it matters: A good market response can show demand for new products and growth.
Supportive ifSurgeons say more people are using and liking the InSet™ I-135RFX.
Worry ifLow adoption rates or negative feedback from surgeons on the InSet™ I-135RFX.